Stock events for Aveanna Healthcare Holdings, Inc. (AVAH)
Aveanna Healthcare Holdings Inc. experienced a stock increase after a quarterly report in August 2025, leading to analyst upgrades. In Q4 2025, revenues rose 27.4% year-over-year, and net income per diluted share improved. Despite beating Q4 earnings, the stock fell over 10% on March 19, 2026, due to a disappointing revenue outlook for 2026. In March 2026, Aveanna announced an agreement to acquire Family First Homecare. As of April 10, 2026, the share price was $6.22, representing an increase of 38.53% over the share price on April 11, 2025. However, short-term share price performance has been weak.
Demand Seasonality affecting Aveanna Healthcare Holdings, Inc.’s stock price
The demand for home and community-based care remains strong. Aveanna Healthcare has indicated that the first quarter is typically its seasonal low point for both operating and free cash flow, with improvement expected throughout the rest of the year.
Overview of Aveanna Healthcare Holdings, Inc.’s business
Aveanna Healthcare Holdings, Inc. is a diversified home care platform providing healthcare services to medically complex patient populations. It operates in three segments: Private Duty Services (PDS), Home Health & Hospice (HHH), and Medical Solutions (MS). Aveanna offers a lower-cost alternative to inpatient care, including respite services.
AVAH’s Geographic footprint
Aveanna Healthcare Holdings, Inc. is headquartered in Atlanta, Georgia, and has a significant geographic footprint across the United States. The company has locations in 38 states, with over 300 branch offices and 366 locations. Aveanna provides pediatric and adult services in homes, community settings, schools, and day treatment centers. The acquisition of Thrive Skilled Pediatric Care, LLC in June 2025 expanded its operational reach. In March 2026, Aveanna announced an agreement to acquire Family First Homecare, further enhancing its footprint.
AVAH Corporate Image Assessment
Aveanna Healthcare Holdings has a "Moderate Buy" consensus rating from analysts. MarketBeat evaluated Aveanna Healthcare as scoring higher than 71% of companies in the medical sector. A strong market reaction to its Q3 2025 earnings report positively impacted its reputation, while a stock decline following the Q4 2025 earnings release negatively impacted its reputation due to a disappointing revenue outlook. Management has noted robust demand for its services, which outstrips its current capacity.
Ownership
Aveanna Healthcare Holdings Inc. has a diverse ownership structure, with significant stakes held by institutional and private equity investors. Major institutional owners include Bain Capital Investors Llc and J.H. Whitney Equity Partners VII, LLC. Bain Capital remains a dominant owner with approximately 39.2%, and J.H. Whitney holds roughly 17.8%. Institutional investors collectively held 87.96% of Aveanna's shares as of August 2025. Insider ownership accounts for approximately 7.80% of the stock.
Ask Our Expert AI Analyst
Price Chart
$6.67